Showing results (281-290 of 490) with videos related to

Sort By:
Pageof 49
Acta Endocrinologica|October 1, 1991
Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind studyJ A Verhelst, A L Froud, R Touzel, et al.
Clinical Endocrinology|May 1, 1985
The effect of dopamine agonist therapy on large functionless pituitary tumoursA Grossman, R Ross, M Charlesworth, et al.
Neuroendocrinology|January 1, 1987
Alpha-adrenergic stimulation of corticotropin secretion by a specific central mechanism in manS Al-Damluji, L Perry, S Tomlin, et al.
Clinical Endocrinology|April 1, 1986
Normal circulating immunoreactive growth hormone releasing factor (hGRF) concentrations in patients with functional hypothalamic hGRF deficiencyA M Sopwith, E S Penny, A Grossman, et al.
Clinical Endocrinology|February 1, 1983
Naloxone inhibits exercise-induced release of PRL and GH in athletesC Moretti, A Fabbri, L Gnessi, et al.
The Quarterly Journal of Medicine|September 1, 1992
Possible mechanism and treatment of o,p'DDD-induced hypercholesterolaemiaV M Maher, P J Trainer, A Scoppola, et al.
Clinical Endocrinology|October 1, 1982
Opiate mediation of amenorrhoea in hyperprolactinaemia and in weight-loss related amenorrhoeaA Grossman, P J Moult, H McIntyre, et al.
Growth Regulation|June 1, 1996
Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitroM Korbonits, J A Little, C Camacho-Hübner, et al.
Clinical Endocrinology|December 1, 1995
Prevalence of Helicobacter pylori in acromegalic patients during treatment with octreotideS L Jones, S Patchett, J V Anderson, et al.
British Medical Journal|July 23, 1977
Metyrapone in long-term management of Cushing's diseaseW J Jeffcoate, L H Rees, S Tomlin, et al.
Pageof 49